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Health care workers are at high risk for expo-
sure to natural rubber latex (NRL) and com-
mercial cleaning solutions; risk assessment
and appropriate control measures should be
implemented to minimize exposure to aller-
gens and irritants and to reduce the risk of
workers for developing occupational asthma.
For sensitized individuals, special attention
should be given to their work and home envi-
ronments, because timely control of exposure
is important to minimize further damage and
long-term adverse effects.
Case Presentation
Patient 1 
A 49-year-old endoscopy nurse, who had
worked in a community hospital for > 20 years,
was diagnosed with allergy to latex after she
experienced frequent peeling of her hands and
local urticaria (hives) after skin contact with
latex (e.g., gloves, condoms, dental proce-
dures). Sensitivity to NRL was documented
by positive radioallergosorbent test (RAST) at
that time. The patient stopped wearing latex
gloves but continued to work in the same hos-
pital environment in the immediate vicinity of
other hospital personnel who used powdered
latex gloves and where latex balloons were
brought in occasionally. Two years later,
despite the avoidance of direct skin contact
with latex products, she developed severe skin
reactions with swelling and urticaria; she also
developed upper and lower respiratory symp-
toms that included allergic rhinitis, hoarse-
ness, wheezing, shortness of breath, chest
tightness, and anaphylaxis. The symptoms
were severe and led to several emergency
department evaluations and treatments. She
was transferred to an administrative area in
the hospital but she remained symptomatic.
The RAST for latex-speciﬁc IgE was repeated
and was negative; however, skin tests for NRL
were unequivocally positive. The patient
developed allergic reactions to foods, and she
started experiencing cough, wheezing, and
shortness of breath when exposed to even low-
levels of irritant chemicals. In addition, she
had positive skin tests to common environ-
mental allergens such as dust mites, pollen,
and cockroaches, requiring desensitization
with allergen immunotherapy. She developed
laryngeal hyperactivity with laryngopharyn-
geal reflux and acid reflux disease. She was
most comfortable in her home, which she
converted to an “allergen free” environment.
She became depressed due to her inability to
work as a nurse and even to leave her home.
She was released from work and referred for
vocational rehabilitation a year later.
The patient was evaluated by several aller-
gists and other specialists, including a gastroen-
terologist, a pulmonologist, a psychiatrist, a
gynecologist, a psychologist, an otorhino-
laryngologist, and two occupational medicine
physicians.
Despite the fact that the patient was
removed from her work environment for
>3years, her symptoms persisted and war-
ranted several daily medications including a
budesonide inhaler, a formoterol inhaler,
loratidine, budesonide nasal spray, omepra-
zole, famotidine, venlafaxine, and albuterol
(as needed). In addition, before leaving home
and in order to prevent severe reactions if she
encountered latex or other allergens and/or
irritants, the patient often premedicated her-
self with cromolyn and ipratropium bromide
inhalers and ipratropium bromide nasal
spray. She also carried self-injectible epineph-
rine and oral diphenhydramine in the event
of a severe allergic reaction.
The patient’s past medical history was sig-
nificant for lactose intolerance, allergy to
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She denied having had any seasonal allergies
before she was diagnosed with latex allergy.
An investigation of the patient’s work
practices revealed that she had used Cidex
(Advanced Sterilization Products, Irvine, CA),
a cold sterilization solution that contains glu-
taraldehyde, a well-known irritant and airway
sensitizer. Cidex was used abundantly and reg-
ularly in open vats and in spray bottles to clean
surfaces. After she was diagnosed with allergy
to latex, the patient stopped using NRL gloves;
however, her co-workers continued to use
powdered latex gloves, and she continued to
work with Cidex until she started experiencing
breathing difﬁculty, and then she switched to
isopropyl spray. 
At home, the patient implemented meas-
ures to make her environment “allergen
free.” She removed existing carpets and rugs
and she used a central vacuum which has a
canister that is taken outdoors to clean. The
house was equipped with central air condi-
tioning, a heat pump, and special ﬁlters, and
she had the ducts cleaned. No one smoked
in the house. She washed the linens in hot
water and covered her bed in material that is
impermeable to dust mites, as advised by her
allergist. She used unscented Tide laundry
detergent (Procter & Gamble, Cincinnati,
OH) to wash her clothes and Palmolive liq-
uid soap (Colgate-Palmolive, New York,
NY) to wash her linoleum ﬂoor. The patient
did not use spray chemicals to clean her
shower and tub; instead, she used hot water
under pressure. She had no indoor plants
and avoided going outside when the grass
was being cut or when the lawn was being
treated. Furthermore, the patient did not
socialize in public places, except for a couple
of restaurants where no latex gloves were
used and smoking was prohibited.
Patient 2
The second patient was a 46-year-old regis-
tered nurse who had worked for 19 years in the
emergency department of the same commu-
nity hospital as patient 1. She had been diag-
nosed with contact dermatitis and mild
intermittent asthma 5 years prior to the diag-
nosis of occupationally induced latex allergy.
The diagnosis was based on her clinical history,
positive NRL skin test, and seropositive latex
speciﬁc IgE by RAST. The patient’s sensitivity
to latex included skin symptoms with swelling
and urticaria, rhinitis, intermittent wheezing,
shortness of breath, and anaphylaxis. She also
developed allergic reactions to several foods,
documented by positive food-speciﬁc IgE by
RAST. She became depressed because of the
severity of her symptoms and their effects on
her ability to work. Although she stopped
using latex gloves, she continued to work in
the emergency department for at least 1 year,
where other personnel in the immediate vicin-
ity used powdered latex gloves. Her symptoms
did not improve; instead, they became severe
and required that she discontinue direct
patient care. She was reassigned to ofﬁce work
only. The patient’s condition worsened to the
point that her respiratory symptoms usually
reoccurred when she walked outside her house,
which was the only place she felt comfortable
and symptom-free. She was released from work
and referred for vocational rehabilitation.
The patient’s past medical history was sig-
nificant for seasonal and perennial allergic
rhinitis. She reported that she had reactions
to cats earlier in her childhood but became
symptom-free as an adult. 
Discussion
Two nurses, who worked at the same commu-
nity hospital, developed severe latex allergy
with dermatologic and respiratory symptoms,
including urticaria and occupationally induced
asthma and anaphylaxis. They also became
sensitized to various chemicals and other envi-
ronmental and food allergens. These nurses
continued to experience respiratory symptoms
that became severe, despite the fact that they
were not using latex. Once the diagnosis of
latex allergy was established, efforts were made
to minimize the employees’ direct skin contact
with latex, but little attention was given to
their work environment. These sensitized
workers remained in environments where
powdered NRL gloves and other respiratory
irritants and potential sensitizers (e.g., glu-
taraldehyde and other disinfectants) were
commonly used and where latex balloons were
brought in occasionally.
Occupational asthma caused by NRL
has been reported in health care workers
(Liss et al.1997; Vandenplas et al. 1995).
Most patients with latex allergy develop der-
matologic symptoms as the first manifesta-
tion, with the most typical skin reaction being
contact urticaria (Sussman et al. 1991). With
continued exposure they may develop upper
and lower respiratory symptoms, angioedema,
and even anaphylaxis (Sussman et al. 1991). 
Allergic reactions to latex consist of
immediate-type hypersensitivity reaction and
delayed-type hypersensitivity reaction. The
latter is a cell-mediated immune reaction in
the skin that usually results from a hypersensi-
tivity to one of the numerous chemicals
added during processing (von Hintzenstern
et al. 1991; Wyss et al. 1993), and it is rarely
associated with systemic manifestations.
However, patients with delayed-type hyper-
sensitivity reactions are at greater risk of
developing immediate reactions due to skin
breakdown and resultant increased exposure
to NRL (Charous et al. 1994; Turjanmaa
1994). Immediate-type hypersensitivity reac-
tions occur within minutes of exposure to
latex products and are mediated by IgE to
various latex proteins. Contact urticaria may
develop in skin exposed to latex. If the latex
proteins are aerosolized, wheezing, rhinitis,
and conjunctivitis may occur. In severely
allergic persons, reactions can progress to ana-
phylaxis. Delayed-type reactions and immedi-
ate-type reactions can also occur concurrently
(Fuchs and Wahl 1992). The clinical mani-
festations of the present cases are consistent
with immediate-type hypersensitivity that is
IgE mediated.
The diagnosis of latex allergy is based on a
comprehensive medical history and diagnostic
tests. The skin-prick test is the preferred and
most useful test in diagnosing type I latex
hypersensitivity (Taylor and Praditsuwan
1996). However, there is a risk of causing
anaphylaxis in highly allergic individuals
(Kelly et al. 1993). The skin-prick test is the
best predictor of latex allergy with 97% sensi-
tivity and 100% speciﬁcity (Ebo et al. 1997),
but the U.S. Food and Drug Administration
(FDA) has not approved standardized latex
solution to be used in the in vivo tests. A skin-
prick test may show negative findings if the
serum used did not contain the speciﬁc latex
allergens responsible for the reaction in the
individual being tested. Therefore, it is
important that testing occur with more than
one type of latex product, as well as with raw
latex (Hamilton and Adkinson 1996). 
The RAST identifies specific IgE anti-
bodies to latex in the blood. Current FDA-
approved in vitro latex IgE assays have lower
sensitivity and speciﬁcity than the skin-prick
test (Ebo et al. 1997) and produce a substan-
tial number (25–28%) of false-negative and
false-positive IgE antibody results (Hamilton
et al. 1999). The presence of allergen-speciﬁc
IgE does not always correlate with clinical
symptoms (Bollinger et al. 2002). The RAST
can conﬁrm an NRL allergy diagnosis, but it
should not be used as a screening tool because
only 50% of a group of individuals identiﬁed
as latex allergic by the skin-prick test had IgE
antibodies to latex by the RAST (Taylor and
Praditsuwan 1996).
In the two cases described above, we were
able to document a history of clinical symp-
toms and positive skin-prick and RAST tests;
we were therefore able to conﬁrm the diagnosis
of NRL allergy.
The existence of underlying atopy
increases the risk of sensitization from work-
place exposure to environmental allergens
(Petsonk 2002). Health care workers who are
atopic develop latex hypersensitivity more fre-
quently than those who are not atopic (Bubak
et al. 1992; Hunt et al. 1995). Taylor and
Praditsuwan (1996) reviewed 44 patients with
latex hypersensitivity and found that 77% of
them were atopic; all but 2 of these patients
were health care workers. 
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to develop sensitivity to other allergens, partic-
ularly foods. The prevalence rates of food
allergy can be as high as 50% in latex-sensitive
individuals, whereas the prevalence rate in the
general population is 2% (Beezhold et al.
1996; Blanco et al. 1994). Both of the nurses
in our study had atopy, and they developed
multiple food allergies. 
Several studies (Heilman et al. 1996;
Tarlo et al. 1994; Tomazic et al. 1994) have
shown that the cornstarch powder used to
lubricate gloves acts as a carrier for latex pro-
teins; when the gloves are removed, latex pro-
teins in dust particles become airborne and
can be readily inhaled, even by those not
wearing the gloves. Using powdered latex
gloves can lead to measurable latex allergen in
the environment on particles that are small
enough to enter the airways and cause sensiti-
zation and symptoms (Swanson et al. 1994;
Swanson and Ramalingam 2002). 
Latex gloves contain various levels of latex
allergens, depending on the brand and type of
latex worn (Alenius et al. 1994). The amount
of allergens aerosolized from the gloves corre-
lates with the number of gloves used at the
premises (Heilman et al. 1996; Sussman et al.
1998; Swanson et al. 1994). Latex aeroaller-
gens are primarily generated by active glove
use (Charous et al. 2000), and from balloons
(Yunginger et al. 1994). High levels of latex
aeroallergens have been detected in areas of
heavy glove use, such as operating rooms,
emergency rooms, and intensive care units
(Heilman et al. 1996). Furthermore, airborne
particles of powder and NRL proteins may
remain suspended for up to 5 hr, contaminat-
ing the air and the ventilating system (Kelly
et al. 1996). Therefore, for latex-sensitive
health care workers with respiratory symp-
toms, the use of nonlatex gloves is only one of
many steps required to reduce and eventually
eliminate overall latex exposure. 
A crucial step in the reduction or elimina-
tion of airborne NRL can be achieved by sub-
stituting nonlatex or powder-free NRL for
powdered gloves. Such substitution has been
found to be an effective prevention strategy
that reduces the incidence of suspected latex
allergy and specifically latex-related occupa-
tional asthma (Allmers et al. 2002; Tarlo et al.
2001; Vanderplas et al. 2002). After occupa-
tional exposure, the rates of sensitization and
NRL-induced asthma rise dramatically in indi-
viduals using powdered NRL gloves but not in
individuals using powder-free gloves (Charous
et al. 2002). The Occupational Health
Surveillance Program of the Massachusetts
Department of Public Health (Boston, MA)
conducted a survey of all acute care and several
chronic care hospitals across the state. Of the
hospitals with a program or policy to reduce
employee exposure to latex, 40% reported a
decrease in latex-related symptoms after the
implementation of their program. Those hos-
pitals with a program in place for > 2 years
were more likely to see decreases in symptoms
than hospitals with a more recently estab-
lished program. Most programs included the
use of nonlatex or latex powder-free gloves
(SENSOR 2002).
Some health care centers and professional
offices have implemented a nonlatex glove
policy throughout the workplace. Others have
converted to powder-free latex in order to
decrease the risk of airborne allergens.
However, most of the health care settings,
including dental ofﬁces, also use a number of
detergents, germicides, and other chemicals
that can also induce and exacerbate allergenic
conditions and play a role in the development
of occupational asthma (Petsonk 2002; Preller
et al. 1996). For example, Cidex, a widely
used cold sterilization solution for endoscopic
equipment, is a well-known respiratory irritant
and sensitizer (DiStefano et al. 1998; Petsonk
2002). In a study that was based on 9 years of
surveillance of work-related and occupational
respiratory disease, McDonald et al. (2000)
reported evidence for an increase in cases of
occupational asthma due to latex and glu-
taraldehyde. The prevalence of work-related
lower respiratory tract symptoms in hospital
endoscopy nurses has been reported to be
8.5% and 66.6% in current employees and ex-
employees, respectively (Vyas et al. 2000). 
It is likely that patient 1’s continuous expo-
sure to Cidex, even after she was diagnosed
with occupational asthma, contributed to her
persistent clinical symptoms and her develop-
ing reactions to all sorts of environmental
irritants. 
In long-term follow-up studies of workers
with sensitizer-induced occupational asthma,
the clinical symptoms have been reported to
persist in approximately70% of affected work-
ers who were no longer exposed to the sensitiz-
ing agent (Chan-Yeung and Malo 1999; Malo
et al. 1992). It has been postulated that once a
person is sensitized to an allergen or chemical,
he or she may develop asthma, which may be
“driven and maintained by the persistence of a
specialized subset of chronically activated
T-memory cells sensitized against an array of
allergenic, occupational, or viral antigens” (Kay
1997). This can explain the fact that asthma
can be aggravated in a nonspeciﬁc manner by
exposure to dust, smoke, fumes, and low levels
of irritant chemicals. Persistence of exposure to
the sensitizing agent leads to worsening of
asthma (Chan-Yeung and Malo 1999), espe-
cially in health care workers with latex allergy
(Charous et al. 1994), and early removal has
been consistently found to be associated with a
better outcome.
To establish a latex-safer environment, an
effective program or policy would include
provision of screening for and surveillance of
workers at risk of becoming sensitized to
latex. Such screening should be based not
only on a positive latex-specific IgE test but
also on a clinical history elicited through a
questionnaire. Indeed, such a program was
implemented at the University of Maryland
Hospital in 1997 (Bollinger et al. 2002). A
latex sensitization rate of 8.2% was found in
the subjects screened. Of note, 45% of the
latex IgE positive employees were asympto-
matic and 21% of the latex speciﬁc IgE nega-
tive employees were symptomatic with latex
exposure. All employees with either latex-
associated symptoms and/or latex-speciﬁc IgE
were advised to avoid latex products. The hos-
pital gradually converted all gloves to powder-
free low protein. Since the program’s
inception, there have been no further latex-
related workers’ compensation claims. Similar
decreases in latex-related workers’ compensa-
tion claims have been described by Tarlo et al.
(1994, 2001) in Canada after conversion to
powder-free gloves. 
Conclusion
In the present report we describe the cases of
two health care professionals who developed
allergy to NRL, persistent occupational
asthma, and subsequent reactions to a variety
of environmental sensitizers and irritants. As
with their cases, when latex allergy is diag-
nosed, special attention should be given to the
patient’s work and home environments,
because timely control of exposure is impor-
tant to minimize further damage and long-
term adverse effects. Health care providers
must be aware of the limitations of the RAST
test and the importance of clinical history in
screening for or diagnosing latex allergy.
Finally, education of personnel about latex
allergy, appropriate handling of potentially
harmful chemicals, and immediate reporting
of adverse health effects is crucial to maintain
a healthy and safe work environment. 
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